UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria

PLoS pathogens, 2018-09, Vol.14 (9), p.e1007191

2018

Volltextzugriff (PDF)

Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome

PloS one, 2017-12, Vol.12 (12), p.e0189768-e0189768

2017

Volltextzugriff (PDF)

High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates

PloS one, 2019-07, Vol.14 (7), p.e0220671-e0220671

2019

Volltextzugriff (PDF)

Characterization of the Sporulation Initiation Pathway of Clostridium difficile and Its Role in Toxin Production

Journal of Bacteriology, 2009-12, Vol.191 (23), p.7296-7305

2009

Volltextzugriff (PDF)

Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota

PloS one, 2014-02, Vol.9 (2), p.e88396

2014

Volltextzugriff (PDF)

Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection

Antibiotics, 2015-07, Vol.4 (3), p.267-298

2015

Volltextzugriff (PDF)

Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains

Infection control and hospital epidemiology, 2007-08, Vol.28 (8), p.920-925

2007

Volltextzugriff (PDF)

Tolevamer Is Not Efficacious in the Neutralization of Cytotoxin in a Human Gut Model of Clostridium difficile Infection

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.2202-2204

2009

Volltextzugriff (PDF)

Non-Toxigenic Clostridioides difficile Strain E4 (NTCD-E4) Prevents Establishment of Primary C. difficile Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model

Antibiotics (Basel), 2023-02, Vol.12 (3), p.435

2023

Volltextzugriff (PDF)

Effects of Exposure of Clostridium difficile PCR Ribotypes 027 and 001 to Fluoroquinolones in a Human Gut Model

Antimicrobial Agents and Chemotherapy, 2009-02, Vol.53 (2), p.412-420

2009

Volltextzugriff (PDF)

Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease

PloS one, 2013-05, Vol.8 (5), p.e63540-e63540

2013

Volltextzugriff (PDF)

Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection

Journal of antimicrobial chemotherapy, 2013-01, Vol.68 (1), p.168-176

2013

Volltextzugriff (PDF)

Molecular epidemiology of predominant and emerging Clostridioides difficile ribotypes

Journal of microbiological methods, 2020-08, Vol.175, p.105974-105974, Article 105974

2020

Volltextzugriff (PDF)

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

Journal of antimicrobial chemotherapy, 2008-11, Vol.62 (5), p.1046-1052

2008

Volltextzugriff (PDF)

Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico

Enfermedades infecciosas y microbiologia clinica (English ed.), 2022-10, Vol.40 (8), p.445-448

2022

Volltextzugriff (PDF)

Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model

Journal of antimicrobial chemotherapy, 2007-07, Vol.60 (1), p.83-91

2007

Volltextzugriff (PDF)

Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model

Journal of antimicrobial chemotherapy, 2014-08, Vol.69 (8), p.2137-2147

2014

Volltextzugriff (PDF)

Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole

Microbial drug resistance (Larchmont, N.Y.), 2021-12, Vol.27 (12), p.1672-1676

2021

Volltextzugriff (PDF)

Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection

Journal of antimicrobial chemotherapy, 2005-10, Vol.56 (4), p.717-725

2005

Volltextzugriff (PDF)

Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico

Enfermedades infecciosas y microbiologia clinica (English ed.), 2022-10, Vol.40 (8), p.445-448

2022

Volltextzugriff (PDF)

Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model

Journal of antimicrobial chemotherapy, 2009-03, Vol.63 (3), p.520-525

2009

Volltextzugriff (PDF)

Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model

Journal of antimicrobial chemotherapy, 2006-11, Vol.58 (5), p.1062-1065

2006

Volltextzugriff (PDF)

Circulation of Highly Drug-Resistant Clostridium difficile Ribotypes 027 and 001 in Two Tertiary-Care Hospitals in Mexico

Microbial drug resistance (Larchmont, N.Y.), 2018-05, Vol.24 (4), p.386-392

2018

Volltextzugriff (PDF)

Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model

Journal of antimicrobial chemotherapy, 2005-06, Vol.55 (6), p.974-982

2005

Volltextzugriff (PDF)

Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model

Journal of antimicrobial chemotherapy, 2008-11, Vol.62 (5), p.1078-1085

2008

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(33)
Microbiology
(27)
Clostridium Difficile
(25)
Humans
(25)
Infectious Diseases
(24)
Pharmacology & Pharmacy
(22)
Biological And Medical Sciences
(19)
Clostridium Difficile - Drug Effects
(19)
Medical Sciences
(17)
Antibiotics
(15)
Anti-Bacterial Agents - Pharmacology
(14)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(14)
Pharmacology. Drug Treatments
(14)
Bacteria
(11)
Microbial Sensitivity Tests
(11)
Gastrointestinal Tract - Microbiology
(10)
Infections
(10)
Ribotyping
(10)
Spores
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria

Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome

High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates

Characterization of the Sporulation Initiation Pathway of Clostridium difficile and Its Role in Toxin Production

Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota

Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection

Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains

Tolevamer Is Not Efficacious in the Neutralization of Cytotoxin in a Human Gut Model of Clostridium difficile Infection

Non-Toxigenic Clostridioides difficile Strain E4 (NTCD-E4) Prevents Establishment of Primary C. difficile Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model

Effects of Exposure of Clostridium difficile PCR Ribotypes 027 and 001 to Fluoroquinolones in a Human Gut Model

Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease

Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection

Molecular epidemiology of predominant and emerging Clostridioides difficile ribotypes

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico

Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model

Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model

Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole

Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection

Analysis of biofilm production and expression of adhesion structures of circulating Clostridioides difficile strains from Mexico

Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model

Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model

Circulation of Highly Drug-Resistant Clostridium difficile Ribotypes 027 and 001 in Two Tertiary-Care Hospitals in Mexico

Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model

Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model

Suchergebnisse filtern